Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T G Uil
Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Related publications
An Ad5[E1-, E2b-]-Her2/Neu Vector Induces Immune Responses and Inhibits HER2/neu Expressing Tumor Progression in Ad5 Immune Mice
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Persistent, Antigen-Specific, Therapeutic Antitumor Immunity by Dendritic Cells Genetically Modified With an Adenoviral Vector to Express a Model Tumor Antigen
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
HER2/neu: An Increasingly Important Therapeutic Target. Part 2: Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology
Clinical Investigation
506. Adenovirus Vectors Transductionally Retargeted to Her2/Neu for Prostate Tumour Treatment
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules
Amino Acids
Organic Chemistry
Biochemistry
Clinical Biochemistry
Transcriptional Repression of the Neu Protooncogene by the Adenovirus 5 E1A Gene Products.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
HER2 (EGFR2; ErbB2; Neu)
Science-Business eXchange
